Atipamezole Market
Global Atipamezole Market Size, Share & Trends Analysis Report by Application (Anti-Sedative and Anti-Toxic), By Route of Administration (Intravenous, Intramuscular, and Others), and by Animal Types (Dogs, Cats, and Others) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global atipamezole market is anticipated to grow at a significant CAGR during the forecast period. The atipamezole is a synthetic alpha 2 adrenergic receptors antagonist drug. It is reserve effect of relaxing and pain killers’ drugs such as medetomidine, xylazine, amitraz and detomidine.. The drugs are used as medicine for an animal like dogs and cats. It is used to treat amitraz and imidazoline decongestants toxicity in the animal. The atipamezole solution for injection is highly preferred in animals such as dogs and cats mostlyAdditionally, rising customer spending towards ownership and adoption of pets is the key driving factor to increasing the atipamezole market. The major companies are launching new products and increasing their production capabilities to produce atipamezole products. For instance, in January 2021, the Dechra launched ATIPAM. It is an injectable 5mg/ml atipamezole Hydrochloride solution is indicated for the reversal of clinic effect of dexmedetomidine and medetomidine hydrochloride in dogs.
Impact of COVID-19 on Global Atipamezole Market
The COVID-19 has impacted the global economy due to a slowdown in the manufacturing of various industries. However, it has exposed the vulnerability of the healthcare system veterinary hospital and also the scarcity of resources for human treatment has a negative impact on animal healthcare. In addition, the logistics and transportation regulation about raw material supply due to lockdown scenarios is a challenge for the atipamezole markets. The lifting of lockdown in the various country of Asia-Pacific has helped pharmaceutical companies to resume their production activity.
Segmental Outlook
The global atipamezole market is segmented based on the application, route of administration, and animal type. Based on the application, the market is segmented into anti-sedative and anti-toxic. Based on the route of administration, the market is sub-segmented into intravenous, intramuscular, and others. Based on the distribution channel the market is sub-segmented into dogs, cats, and others. Among these, the dogs by animal type segment are anticipated to propel the growth of the market over the forecast period. Increasing customer spending toward the ownership and adoption of dogs is one of the key drivers that is catalyzing growth of the atipamezole market.
Global Atipamezole Market Share by Animal Type, 2021 (%)
The Dogs Segment is Anticipated to Hold a Prominent Share in the Global Atipamezole Market
Dogs by animal type are anticipated to hold more favour in the market as compared to other pets. The rising pet ownership especially for dogs in major economies such as the US, China and India is the key factor the demand for product is also surging leading to the market growth. PeFor instance, in 2019, according to the survey conducted report by American Pet Products Association (APPA), the U.S. had approximately more than 92 million pet dogs. Apart from this, the increase in average spending on animal healthcare by pet owners is further acelarating the market growth. For instance, in 2019, the annual speding on animal heathcare products and services in the US reached to $95.7 billion as per the American Pet Products Association. Veterinary care and product sales came in at $29.3 billion. Moreover, 38.4% of households owns atlest one dog (or 48,255,413 Number of households). In addition, Veterinary visits per household per year is the US for dog is 2.4 mean.
Regional Outlooks
The global atipamezole market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The Asia-Pacific regional atipamezole market is expected to hold a prominent share due to the presence of several key market players and their focus towards new drug development.
Global Atipamezole Market Growth, by Region 2022-2028
The Asia Pacific region is estimated to Hold the Major Share in the Global Atipamezole Market
Asia Pacific is anticipated to hold a prominent share in the market. It is a highly lucrative market for atipamezole. The region is expected to expand high CAGR during the forecast period in this market. In addition, the government initiative in developing countries towards the innovation of animal health infrastructure and increase in awareness about the therapeutics factors are anticipated to fuel the atipamezole market in Asia-Pacific. For instance, in February 2019, the U.S. Food and Drug Administration approved the modern Veterinary Therapeutics product Revertidine.
Market Players Outlook
The major companies serving the global atipamezole market include Zoetis Inc., Merck KGaA, Pfizer Inc., Vetoquinol SA, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2019, the zoetis service LLC entered into an agreement with Texas A&M University Health Science Center for Innovation in Advanced Development and manufacturing to establish the research facility.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global atipamezole market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Atipamezole Market
• Recovery Scenario of Global Atipamezole Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Merck KGaA
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Orion Corp.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Pfizer Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Vetoquinol SA
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Zoetis Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Atipamezole Market by Application
4.1.1. Anti-Sedative
4.1.2. Anti-Toxic
4.2. Global Atipamezole Market by Route of Administration
4.2.1. Intravenous
4.2.2. Intramuscular
4.2.3. Others
4.3. Global Atipamezole Market by Animal Type
4.3.1. Dogs
4.3.2. Cats
4.3.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Axience SAS
6.2. Alvetra & werfft GmbH
6.3. Ceva sant Animale S.A.
6.4. Chanelle Pharma Group
6.5. CP Pharmaceuticals Ltd.
6.6. Dr. E. Graeub AG
6.7. Eli Lilly and Co.
6.8. Forte Healthcare Ltd.
6.9. Merck & Co. Inc.
6.10. Modern Veterinary Therapeutics
6.11. Orion Corp.
6.12. Pfizer Inc.
6.13. Sogeval Laboratories Inc.
6.14. Troy Laboratories Pvt. Ltd
6.15. Vetoquinol UK Ltd.
6.16. VetPharm Inc.
6.17. Zoetis Services LLC
1. GLOBAL ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
2. GLOBAL ANTI-SEDATIVE ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL ANTI-TOXIC ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
5. GLOBAL INTRAVENOUS ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL INTRAMUSCULAR ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ANIMALTYPE, 2021-2028 ($ MILLION)
8. GLOBAL DOGS ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL CATS ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
13. NORTH AMERICAN PORTABLE BLENDERS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
14. NORTH AMERICAN ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
15. EUROPEAN ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. EUROPEAN ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. EUROPEAN ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
18. EUROPEAN ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
23. REST OF THE WORLD ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. REST OF THE WORLD ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25. REST OF THE WORLD ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
26. REST OF THE WORLD ATIPAMEZOLE MARKET RESEARCH AND ANALYSIS BY ANIMAL TYPE, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL ATIPAMEZOLE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL ATIPAMEZOLE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL ATIPAMEZOLE MARKET, 2021-2028 (%)
4. GLOBAL ATIPAMEZOLE MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
5. GLOBAL ANTI-SEDATIVE ATIPAMEZOLE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL ANTI-TOXIC ATIPAMEZOLE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL ATIPAMEZOLE MARKET SHARE BY ROUTE OF ADMINISTRATION, 2021 VS 2028 (%)
8. GLOBAL INTRAVENOUS ATIPAMEZOLE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL INTRAMUSCULAR ATIPAMEZOLE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL ATIPAMEZOLE MARKET SHARE BY ANIMAL TYPE, 2021 VS 2028 (%)
11. GLOBAL DOGS ATIPAMEZOLE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL CATS ATIPAMEZOLE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL ATIPAMEZOLE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. US ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
15. CANADA ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
16. UK ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
17. FRANCE ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
18. GERMANY ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
19. ITALY ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
20. SPAIN ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
21. REST OF EUROPE ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
22. INDIA ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
23. CHINA ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
24. JAPAN ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
25. SOUTH KOREA ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF ASIA-PACIFIC ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF THE WORLD ATIPAMEZOLE MARKET SIZE, 2021-2028 ($ MILLION)
